✦ LIBER ✦

462 Intravenous and oral ibandronate reduce the risk of skeletal related events in patients with metastatic bone disease

✍ Scribed by J.-J. Body; D. Tripathy; M. Pecherstorfer; B. Bergstrom

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous and oral ibandronate reduce

✍ D Tripathy; J.-J Body; I.J Diel; B Bergstrom 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 164 KB

430 POSTER Efficacy of ibandronate for t

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

443 Safety and tolerability of oral iban

✍ I. Diel; M. Pecherstorfer; J.J. Body; D. Tripathy; B. Bergstrom 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Efficacy of ibandronate for the treatmen

✍ P. HERAS; K. KRITIKOS; A. HATZOPOULOS; A.-P. GEORGOPOULOU 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Cost-effectiveness of oral ibandronate c

✍ E. Cock; J. Hutton; P. Canney; J. J. Body; P. Barrett-Lee; M. P. Neary; G. Lewis 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 200 KB

Prevalence and risk factors of bone meta

✍ Yamashiro, Hiroyasu; Takada, Masahiro; Nakatani, Eiji; Imai, Shiro; Yamauchi, Ak 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 385 KB